Prot# KSB311R/CIII/001: A Phase III Multicenter Study of Intratumoral/Interstitial Therapy with TransMID Compared to Best Standard of Care in Patients with Progressive and/or Recurrent, Non-Resectable Glioblastoma Multiforme

Project: Research project

Project Details

StatusFinished
Effective start/end date4/13/04 → 12/19/05

Funding

  • PPD Development (KSB311R/CIII/001)
  • Xenova Biomedix Ltd. (KSB311R/CIII/001)